Promoted Content Promoted Content

X

Find the latest news about Janssen Pharmaceutical aggregated by PharmaCompass.com.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Janssen Pharmaceutical
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
1125 Trenton-Harbourton Road, P.O. Box 200, Titusville, NJ 08560
Telephone
Telephone
+1-800-775-5514.
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://www.indianpharmapost.com/news/janssen-tremfya-excels-as-psoriasis-treatment-outshining-il-17s-says-globaldata-14200

INDIAN PHARMA POST
01 Jun 2023

https://www.prnewswire.com/news-releases/janssen-submits-new-drug-application-to-us-fda-seeking-approval-of-investigational-single-tablet-combination-therapy-of-macitentan-and-tadalafil-for-treatment-of-patients-with-pulmonary-arterial-hypertension-pah-301834852.html

PR NEWSWIRE
30 May 2023

https://www.globenewswire.com/news-release/2023/05/25/2675919/0/en/Janssen-Seeks-European-Commission-Approval-of-a-New-Indication-for-CARVYKTI-ciltacabtagene-autoleucel-cilta-cel-for-the-Earlier-Treatment-of-Patients-with-Relapsed-and-Refractory-M.html

GLOBENEWSWIRE
25 May 2023

https://johnsonandjohnson.gcs-web.com/static-files/4120e707-3112-4f0b-a1d2-7015893e855c

PRESS RELEASE
25 May 2023

https://endpts.com/janssen-reports-decline-in-2022-net-prices-as-out-of-pocket-costs-grow/

Nicole DeFeudis ENPTS
25 May 2023

https://johnsonandjohnson.gcs-web.com/static-files/a6b05ebe-8b48-40ad-8d48-cb8cf68c3c96

PRESS RELEASE
18 May 2023

https://www.prnewswire.com/news-releases/protagonist-reports-positive-results-from-phase-1-and-pre-clinical-studies-of-oral-interleukin-23-receptor-antagonist-jnj-2113-301823039.html

PR NEWSWIRE
12 May 2023

https://www.clinicaltrialsarena.com/news/janssen-tremyfa-ulcerative-colitis/

CLINICAL TRIALS ARENA
10 May 2023

https://www.prnewswire.com/news-releases/first-phase-3-tremfya-guselkumab-data-in-inflammatory-bowel-disease-show-positive-induction-results-among-patients-with-moderately-to-severely-active-ulcerative-colitis-301818808.html

PR NEWSWIRE
09 May 2023

https://www.fiercebiotech.com/biotech/jj-refuels-car-t-ambitions-245m-upfront-cellular-biomedicine-pair-therapies

James Waldron FIERCE BIOTECH
02 May 2023
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY